These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 36891590)

  • 21. Healthcare personnel frequently have positive severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antigen tests 5 days or more after diagnosis of coronavirus disease 2019 (COVID-19).
    Stiefel U; Bhullar D; Zabarsky TF; Palmieri NF; Diaz KD; Torres-Teran MM; Donskey CJ
    Infect Control Hosp Epidemiol; 2022 Dec; 43(12):1985-1987. PubMed ID: 35131000
    [No Abstract]   [Full Text] [Related]  

  • 22. Study on IoT for SARS-CoV-2 with healthcare: present and future perspective.
    Rahman A; Rahman M; Kundu D; Karim MR; Band SS; Sookhak M
    Math Biosci Eng; 2021 Nov; 18(6):9697-9726. PubMed ID: 34814364
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Timing of last COVID-19 vaccine dose and SARS-CoV-2 breakthrough infections in fully (boosted) vaccinated healthcare personnel.
    Maltezou HC; Gamaletsou MN; Giannouchos TV; Koukou DM; Karapanou A; Sourri F; Syrimi N; Lemonakis N; Peskelidou E; Papanastasiou K; Souliotis K; Lourida A; Panagopoulos P; Hatzigeorgiou D; Sipsas NV
    J Hosp Infect; 2023 Feb; 132():46-51. PubMed ID: 36473554
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
    Stratton CW; Tang YW; Lu H
    J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Healthcare-associated infections during the coronavirus disease 2019 (COVID-19) pandemic.
    Palmore TN; Henderson DK
    Infect Control Hosp Epidemiol; 2021 Nov; 42(11):1372-1373. PubMed ID: 34766901
    [No Abstract]   [Full Text] [Related]  

  • 26. Severe Acute Respiratory Syndrome Coronavirus 2 Nucleocapsid Antigen in Urine of Hospitalized Patients With Coronavirus Disease 2019.
    Veyrenche N; Pisoni A; Debiesse S; Bollore K; Bedin AS; Makinson A; Niel C; Alcocer-Cordellat C; Mondain AM; Le Moing V; Van de Perre P; Tuaillon E
    J Infect Dis; 2022 Sep; 226(5):812-821. PubMed ID: 35230450
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rational allocation of coronavirus disease 2019 (COVID-19) vaccines to healthcare personnel and patients: A role for antimicrobial stewardship programs?
    Nori P; Patel PK; Stevens MP
    Infect Control Hosp Epidemiol; 2022 Feb; 43(2):263-265. PubMed ID: 33323155
    [No Abstract]   [Full Text] [Related]  

  • 28. Impact of coronavirus disease 2019 (COVID-19) on healthcare-associated infections: An update and perspective.
    Assi MA; Doll M; Pryor R; Cooper K; Bearman G; Stevens MP
    Infect Control Hosp Epidemiol; 2022 Jun; 43(6):813-815. PubMed ID: 33706842
    [No Abstract]   [Full Text] [Related]  

  • 29. Hospital-acquired coronavirus disease 2019 (COVID-19) among patients of two acute-care hospitals: Implications for surveillance.
    Trick WE; Santos CAQ; Welbel S; Tseng M; Zhang H; Donceras O; Martinez AI; Lin MY
    Infect Control Hosp Epidemiol; 2022 Dec; 43(12):1761-1766. PubMed ID: 35438067
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Occupational COVID-19 exposures and secondary cases among healthcare personnel.
    Ibiebele J; Silkaitis C; Dolgin G; Bolon M; JaneCullen ; Zembower T
    Am J Infect Control; 2021 Oct; 49(10):1334-1336. PubMed ID: 34375702
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Occupational risk factors for severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection among healthcare personnel: A cross-sectional analysis of subjects enrolled in the COVID-19 Prevention in Emory Healthcare Personnel (COPE) study.
    Howard-Anderson JR; Adams C; Sherman AC; Dube WC; Smith TC; Edupuganti N; Chea N; Magill SS; Espinoza DO; Zhu Y; Phadke VK; Edupuganti S; Steinberg JP; Lopman BA; Jacob JT; Collins MH; Fridkin SK
    Infect Control Hosp Epidemiol; 2022 Mar; 43(3):381-386. PubMed ID: 33557990
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of the Healthcare Surface Environment in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Transmission and Potential Control Measures.
    Kanamori H; Weber DJ; Rutala WA
    Clin Infect Dis; 2021 Jun; 72(11):2052-2061. PubMed ID: 32985671
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Healthcare-associated outbreak of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) in a rural hospital in Missouri, March 2020.
    Turabelidze G; Faulconer BC; Lawrence SJ; Pierce A; Smith BK; Fremont DH
    Infect Control Hosp Epidemiol; 2021 Nov; 42(11):1395-1396. PubMed ID: 33077014
    [No Abstract]   [Full Text] [Related]  

  • 34. Is it time for us to account for the impact of coronavirus disease 2019 (COVID-19) on healthcare-associated infections?
    Fakih MG; Sturm LK; Thyagarajan RV; Mondy KE
    Infect Control Hosp Epidemiol; 2022 Dec; 43(12):1960-1961. PubMed ID: 34743771
    [No Abstract]   [Full Text] [Related]  

  • 35. [Antibody Screening and Risk Assessment of Healthcare Professionals in the COVID-19 Pandemic].
    Gümüş HH; Demiroğlu YZ; Alışkan HE; Ödemiş İ; Ceylan Ö; Poçan AG; Karagün Ö
    Mikrobiyol Bul; 2021 Jul; 55(3):357-373. PubMed ID: 34416802
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SARS-CoV-2 Infection in Healthcare Professionals and General Population During "First Wave" of COVID-19 Pandemic: A Cross-Sectional Study Conducted in Sicily, Italy.
    Costantino C; Cannizzaro E; Verso MG; Tramuto F; Maida CM; Lacca G; Alba D; Cimino L; Conforto A; Cirrincione L; Graziano G; Palmeri S; Pizzo S; Restivo V; Casuccio A; Vitale F; Mazzucco W
    Front Public Health; 2021; 9():644008. PubMed ID: 34055716
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SARS-CoV-2 seroconversions and chains of infection in healthcare professionals in a German maximum care provider (The CoSHeP study).
    van Bremen K; Monin M; Eis-Hübinger AM; Marx B; Aldabaggh S; Streeck H; Wasmuth JC; Menting T; Schlabe S; Rieke GJ; Schwarze-Zander C; Rockstroh JK; Boesecke C
    Infection; 2021 Oct; 49(5):1039-1043. PubMed ID: 34143409
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Healthcare worker seroconversion for SARS-CoV-2 at two large health systems in San Diego.
    Nicholson L; McLawhon RW; Kurian S; Fitzgerald RL; Case J; Marsh C; Quigley M
    Am J Infect Control; 2021 Apr; 49(4):506-507. PubMed ID: 33388312
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Severe acute respiratory coronavirus virus 2 (SARS-CoV-2) seroprevalence in healthcare personnel in northern California early in the coronavirus disease 2019 (COVID-19) pandemic.
    Rosser JI; Röltgen K; Dymock M; Shepard J; Martin A; Hogan CA; Blomkalns A; Mathew R; Parsonnet J; Pinsky BA; Maldonado YA; Boyd SD; Chang SI; Holubar M;
    Infect Control Hosp Epidemiol; 2021 Sep; 42(9):1053-1059. PubMed ID: 33292895
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Unrecognized severe acute respiratory coronavirus virus 2 (SARS-CoV-2) seroprevalence among healthcare personnel in a low-prevalence area.
    Shah VP; Hainy CM; Swift MD; Breeher LE; Theel ES; Sampathkumar P
    Infect Control Hosp Epidemiol; 2021 Dec; 42(12):1532-1534. PubMed ID: 33213552
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.